Introduction {#s1}
============

Glaucoma, which causes optic nerve damage and visual field loss, is the leading causes of irreversible blindness worldwide [@pone.0046632-Quigley1]. A family history of the disease has long been recognized as a major risk factor for glaucoma, suggesting that specific gene defects contribute to the pathogenesis of the disorder [@pone.0046632-Weih1]. The most common form of glaucoma is primary open-angle glaucoma (POAG), which is characterized with typical optic disc damage and visual field defects, in an eye which does not have evidence of angle closure on gonioscopy, accompanied with elevated or normal intraocular pressure (IOP). Several chromosomal loci have now been reported as linked to POAG, such as myocilin (MYOC; GLC1A, MIM 601652), optineurin (OPTN; GLC1E, MIM 602432), and WD repeat domain 36 (WDR36; GLC1G, MIM 609669) [@pone.0046632-Wiggs1].

The MYOC gene, also known as trabecular meshwork-inducible glucocorticoid response (TIGR) gene, was the first discovered to be linked to POAG in 1997 [@pone.0046632-Stone1]. Several large studies have suggested that MYOC mutations are associated with 2% to 4% of POAG in patient populations worldwide, with more than 30 disease-associated mutations identified [@pone.0046632-Fingert1], [@pone.0046632-Orwig1]. The overall frequency of disease-causing mutations at MYOC is similar among African (4.44%), Caucasian (3.86%) and Asian (3.30%) probands with POAG [@pone.0046632-Gong1]. Most disease-associated mutations at MYOC exist only in a specific racial group. The most frequent mutation Gln368Stop was present only in Caucasian descendants, and the second most frequent mutation Arg46Stop was shared only by Asian populations. However, the association of MYOC with POAG has been a source of controversy. After the initial discovery of POAG-causing mutations, the mutations were subsequently observed in controls, which were considered as non-disease-causing polymorphisms [@pone.0046632-Faucher1], [@pone.0046632-Jansson1]. Otherwise, reports published previously showed apparent non-consistent results. In familial studies, over four fifths Gln368Stop-carriers did not have POAG [@pone.0046632-Allingham1]. Also, the most frequent mutation Arg46Stop in Asians was even more often found in normal controls than in POAG probands [@pone.0046632-Pang1]. Because the currently published studies only refer to a modest sample size, each one might not achieve a reliable conclusion. Hence, to investigate the association of the MYOC genetic variation with POAG susceptibility, a newly meta-analysis of all of the available case-control studies was carried out.

Results {#s2}
=======

A total of 665 articles were identified across PubMed and Embase, and 57 full-text articles were retrieved. Finally, 32 studies met criteria and were included in the present meta-analysis [@pone.0046632-Faucher1], [@pone.0046632-Jansson1], [@pone.0046632-Pang1]--[@pone.0046632-Whigham1]. The flow of study selection is shown in [Figure 1](#pone-0046632-g001){ref-type="fig"}, and the detailed characteristics of the studies were shown in [Table 1](#pone-0046632-t001){ref-type="table"}. 6,729 patients and 4,871 controls were included in this study. Among those 32 included studies, 18 were conducted in Asians, 12 in Caucasians, and 1 in mixed. There were 19 studies for high-tension glaucoma (HTG), 1 study for normal-tension glaucoma (NTG), and 11 studies for both HTG and NTG. For R46X, R76K, Y347Y, T353I, and Q368X, meta-analyses were conducted within 11, 26, 11, 12, and 9 studies, respectively.

![Flow diagram of study selection.](pone.0046632.g001){#pone-0046632-g001}
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###### Characteristics of publications included in meta-analysis of myocilin polymorphism and POAG.
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  Reference                           Country                         Ethnicity                Patients                            Controls                       No. (case/control)
  --------------------- ------------------------------------ --------------------------- -------------------- -------------------------------------------------- --------------------
  Alward 1998                   Iowa; Australia; US                   Caucasian               POAG (HTG)         General population and healthy participants           716/596
  Yoon 1999                            Korea                            Asian                 POAG (HTG)                  Non-glaucoma participants                     45/106
  Fingert 1999           Iowa; Australia; US; Canada; Japan   Caucasian; African; Asian       POAG (HTG)         General population and healthy participants           1693/793
  Kubota 2000                          Japan                            Asian             POAG (HTG and NTG)              Non-glaucoma participants                    140/100
  Lam 2000                             China                            Asian                 POAG (HTG)                  Non-glaucoma participants                     91/132
  Vázquez 2000                         Spain                          Caucasian               POAG (HTG)                      General population                        79/90
  Mabuchi 2001                         Japan                            Asian             POAG (HTG and NTG)              Non-glaucoma participants                    233/100
  Mataftsi 2001                     Switzerland                       Caucasian           POAG (HTG and NTG)              Non-glaucoma participants                     117/50
  Fan 2002                             China                            Asian                 POAG (HTG)                  Non-glaucoma participants                     82/150
  Faucher 2002                         Canada                         Caucasian               POAG (HTG)         General population and healthy participants           293/107
  Hulsman 2002                      Netherlands                       Caucasian           POAG (HTG and NTG)              Non-glaucoma participants                     50/100
  Mukhopadhyay 2002                    India                            Asian                 POAG (HTG)                  Non-glaucoma participants                     56/51
  Pang 2002                            China                            Asian                 POAG (HTG)                  Non-glaucoma participants                    201/388
  Izumi 2003                           Japan                            Asian                 POAG (NTG)                  Non-glaucoma participants                     80/100
  Jansson 2003                         Sweden                         Caucasian               POAG (HTG)                  Non-glaucoma participants                    200/200
  Melki 2003a                          France                         Caucasian           POAG (HTG and NTG)                 Healthy participants                      237/108
  Melki 2003b                         Morocco                         Caucasian               POAG (HTG)                      General population                        57/60
  Fan 2004a                            China                            Asian                 POAG (HTG)                  Non-glaucoma participants                    157/155
  Fan 2004b                            China                            Asian                 POAG (HTG)                  Non-glaucoma participants                     32/96
  Ishikawa 2004                        Japan                            Asian                 POAG (HTG)                     Healthy participants                      171/100
  Fan 2005                             China                            Asian             POAG (HTG and NTG)              Non-glaucoma participants                    400/281
  Rakhmanov 2005                       Russia                         Caucasian           POAG (HTG and NTG)              Non-glaucoma participants                    170/100
  Funayama 2006                        Japan                            Asian             POAG (HTG and NTG)              Non-glaucoma participants                    532/240
  Yao 2006                             China                            Asian             POAG (HTG and NTG)              Non-glaucoma participants                     142/77
  Bhattacharjee 2007                   India                            Asian                 POAG (HTG)       General population and non-glaucoma participants        315/100
  Kumar 2007                           India                            Asian             POAG (HTG and NTG)                 Healthy participants                      251/100
  Lopez-Martinez 2007                  Spain                          Caucasian               POAG (HTG)                     Healthy participants                       110/98
  Yen 2007                             China                            Asian                 POAG (HTG)                     Healthy participants                       48/100
  Bayat 2008                            Iran                          Caucasian               POAG (HTG)                     Healthy participants                       23/100
  Jia 2009                             China                            Asian                 POAG (HTG)                  Non-glaucoma participants                    176/200
  Chen 2011                            China                            Asian                 POAG (HTG)                  Non-glaucoma participants                    118/150
  Whigham 2011                           US                            African            POAG (HTG and NTG)              Non-glaucoma participants                    113/131

POAG: primary open angle glaucoma; HTG: high-tension glaucoma; NTG: normal-tension glaucoma.

The association between the MYOC Q368X mutation and POAG was investigated with a total of 3,820 cases and 2,144 controls. Meta-analysis suggested that Q368X mutation carriage might be a risk factor for POAG with a summarized OR of 4.68 (95%CI, 2.02--10.85) ([Figure 2](#pone-0046632-g002){ref-type="fig"}), and no heterogeneity between studies (P = 0.76; I^2^ = 0.00%) was observed. There was no publication bias (P = 0.40 for Begg rank correlation analysis; P = 0.30 for Egger weighted regression analysis). In subgroup analysis by ethnicity, the association was significant in Caucasians, but not in Asians and Africans ([Table 2](#pone-0046632-t002){ref-type="table"}). The association was also significant for HTG.

![Meta-analysis of the association between primary open-angle glaucoma and myocilin Q368X mutation.](pone.0046632.g002){#pone-0046632-g002}
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###### Summary odds ratios from the meta-analysis of the association between primary open-angle glaucoma and myocilin polymorphisms.
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  Polymorphism and subgroup    No. of studies   Event/Total (%)   Odds ratios (95% CI)   Test for heterogeneity           Test for overall effect          
  --------------------------- ---------------- ----------------- ---------------------- ------------------------ ----------------------------------------- -----------------------
  **Q368X**                                                                                                                                                
  All                                9           69/3820 (1.8)        4/2144 (0.2)         4.68 (2.02, 10.85)      X^2^ = 4.974, P = 0.760, I^2^ = 0.00%    Z = 3.598, P = 0.000
  Africans                           1            1/312 (0.3)          0/90 (0.0)          0.87 (0.04, 21.58)      X^2^ = 0.000, P = 1.000, I^2^ = 0.00%    Z = −0.084, P = 0.933
  Asians                             1            2/315 (0.6)         0/100 (0.0)          1.60 (0.08, 33.67)      X^2^ = 0.000, P = 1.000, I^2^ = 0.00%    Z = 0.304, P = 0.761
  Caucasians                         8           66/3086 (2.1)        4/1905 (0.2)         5.17 (2.16, 12.40)      X^2^ = 4.563, P = 0.713, I^2^ = 0.00%    Z = 3.680, P = 0.000
  HTG                                7           52/3446 (1.5)        4/1986 (0.2)         4.26 (1.69, 10.73)      X^2^ = 4.467, P = 0.614, I^2^ = 0.00%    Z = 3.076, P = 0.002
  **T353I**                                                                                                                                                
  All                                12          44/3452 (1.3)       25/2609 (1.0)         2.17 (1.32, 3.57)       X^2^ = 6.308, P = 0.852, I^2^ = 0.00%    Z = 3.041, P = 0.002
  Asian                              12          44/3452 (1.3)       25/2609 (1.0)         2.17 (1.32, 3.57)       X^2^ = 6.310, P = 0.852, I^2^ = 0.00%    Z = 3.040, P = 0.002
  NTG                                2            3/154 (1.9)         5/358 (1.5)          1.58 (0.40, 6.22)       X^2^ = 0.548, P = 0.459, I^2^ = 0.00%    Z = 0.656, P = 0.512
  HTG                                12          42/3298 (1.3)       25/2609 (1.0)         2.26 (1.37, 3.72)       X^2^ = 5.989, P = 0.874, I^2^ = 0.00%    Z = 3.176, P = 0.001
  **Y347Y**                                                                                                                                                
  All                                11         174/3715 (4.7)       85/2164 (3.9)         1.20 (0.91, 1.57)       X^2^ = 3.719, P = 0.959, I^2^ = 0.00%    Z = 1.304, P = 0.192
  Africans                           2            8/425 (1.9)         2/221 (0.9)          1.37 (0.24, 7.88)       X^2^ = 0.857, P = 0.355, I^2^ = 0.00%    Z = 0.348, P = 0.728
  Asians                             2            9/457 (2.0)         0/177 (0.0)          3.24 (0.38, 27.46)      X^2^ = 0.308, P = 0.579, I^2^ = 0.00%    Z = 1.079, P = 0.281
  Caucasians                         8          157/2736 (5.7)       83/1717 (4.8)         1.19 (0.91, 1.57)       X^2^ = 2.057, P = 0.957, I^2^ = 0.00%    Z = 1.259, P = 0.208
  NTG                                2            3/68 (4.4)          7/177 (4.0)          1.89 (0.44, 8.23)       X^2^ = 0.421, P = 0.516, I^2^ = 0.00%    Z = 0.852, P = 0.394
  HTG                                6          157/3041 (5.2)       77/1747 (4.4)         1.22 (0.92, 1.63)       X^2^ = 2.522, P = 0.773, I^2^ = 0.00%    Z = 1.393, P = 0.164
  **R76K**                                                                                                                                                 
  All                                23         769/5371 (14.3)     608/3340 (18.2)        0.86 (0.69, 1.08)      X^2^ = 45.281, P = 0.002, I^2^ = 51.42%   Z = −1.319, P = 0.187
  Africans                           2            1/425 (0.2)         1/221 (0.5)          0.58 (0.06, 5.59)       X^2^ = 0.126, P = 0.723, I^2^ = 0.00%    Z = −0.473, P = 0.636
  Asians                             16         613/2999 (20.4)     461/2301 (20.0)        0.89 (0.75, 1.06)      X^2^ = 15.748, P = 0.399, I^2^ = 4.75%    Z = −1.339, P = 0.180
  Caucasians                         7          155/1947 (8.0)       146/800 (18.3)        0.62 (0.48, 0.81)      X^2^ = 44.682, P = 0.000, I^2^ = 86.57%   Z = −3.586, P = 0.000
  NTG                                5           64/625 (10.2)       85/798 (10.7)         1.19 (0.83, 1.73)      X^2^ = 4.586, P = 0.332, I^2^ = 12.78%    Z = 0.939, P = 0.348
  HTG                                17         559/4092 (13.7)     474/2701 (17.5)        0.84 (0.65, 1.08)      X^2^ = 37.401, P = 0.002, I^2^ = 57.22%   Z = −1.355, P = 0.175
  **R46X**                                                                                                                                                 
  All                                12          34/1826 (1.8)       35/1884 (1.9)         1.02 (0.61, 1.70)       X^2^ = 7.664, P = 0.743, I^2^ = 0.00%    Z = 0.073, P = 0.942
  Asians                             12          34/1826 (1.8)       35/1884 (1.9)         1.02 (0.61, 1.70)       X^2^ = 7.664, P = 0.743, I^2^ = 0.00%    Z = 0.073, P = 0.942
  NTG                                4            8/348 (2.3)         8/558 (1.4)          1.86 (0.60, 5.72)       X^2^ = 2.659, P = 0.447, I^2^ = 0.00%    Z = 1.080, P = 0.280
  HTG                                10          26/1359 (1.9)       35/1684 (2.1)         0.93 (0.55, 1.60)       X^2^ = 5.419, P = 0.796, I^2^ = 0.00%    Z = −0.250, P = 0.803

It has been shown in [Figure 3](#pone-0046632-g003){ref-type="fig"} that the T353I mutation was significantly associated with POAG (OR, 2.17; 95% CI, 1.32--3.57), with no evidence of heterogeneity among the overall 12 studies (P = 0.85; I^2^ = 0.00%). No publication bias was observed (P = 0.58 for Begg rank correlation analysis; P = 0.97 for Egger weighted regression analysis). Significant relation was also observed in Asians ([Table 2](#pone-0046632-t002){ref-type="table"}). The ORs of T353I mutation were 2.26 (1.37--3.72) for HTG and 1.58 (0.40--6.22) for NTG.

![Meta-analysis of the association between primary open-angle glaucoma and myocilin T353I mutation.](pone.0046632.g003){#pone-0046632-g003}

Meta-analyses suggested that the other three MYOC polymorphisms Y347Y, R76K, and R46X were not associated with increased risk of POAG, with summarized ORs of 1.20 (0.91--1.57), 0.86 (0.69--1.08), and 1.02 (0.61--1.70) ([Table 2](#pone-0046632-t002){ref-type="table"}). There was also no significant relation in the subgroup analyses by ethnicity or diagnosis criteria.

Discussion {#s3}
==========

Myocilin is an eye protein found in the trabecular extracellular matrix, within the anatomic region that controls fluid flow, therefore, it might be the source of the resistance to aqueous humor outflow that causes the elevation of IOP in POAG [@pone.0046632-Orwig1]. Previous genome-wide analysis in a *Drosophila* ocular hypertension model identified transcripts with altered regulation and showed induction of the unfolded protein response upon overexpression of transgenic human glaucoma-associated myocilin [@pone.0046632-Challa1]. This meta-analysis examined the MYOC Q368X, T353I, Y347Y, R76K, and R46X polymorphisms and their relationship to susceptibility to POAG. Thirty two articles addressing the most widely studied MYOC polymorphisms were identified, and their effects were summarized by means of meta-analysis. Significant associations with POAG susceptibility were observed for two loci mutations Q368X and T353I. Q368X variant carried near a 4.7-fold increased risk of POAG, and T353I variant carried near a 2.2-fold increase in POAG risk.

Strength of the associations in the subgroup analyses with respect to study population was not consistent. In Caucasians, significant association was observed for Q368X mutation, and, in Asians, it was for T353I. Because the rate of Q368X mutation was rare, of being 0.6% in Asians and 0.3% in Africans respectively [@pone.0046632-Fingert2], [@pone.0046632-Bhattacharjee1], the single study with small sample size might lead to the "negative" result in two populations. However, the absence of Q368X mutation was observed in other African [@pone.0046632-Melki2], [@pone.0046632-Whigham1], [@pone.0046632-Challa1] and Asian [@pone.0046632-Fingert2], [@pone.0046632-Lam1], [@pone.0046632-Mabuchi1], [@pone.0046632-Yao1] populations. Also, the T353I mutation was absent in Caucasian and African populations. Therefore, a different pattern of MYOC sequence variants might exist among different ethnic populations.

Normal tension glaucoma is a common form of open-angle glaucoma throughout the world, and yet there are many unanswered questions regarding both the mechanisms of the optic neuropathy. A certain level of IOP is the predominant causative risk factor in POAG, while additional IOP-independent factors take increasing importance in NTG [@pone.0046632-Shields1]. It was proved that NTG was associated with mutations in OPTN [@pone.0046632-Wiggs2]. However, a previous meta-analysis demonstrated no evidence of strong association between OPTN polymorphisms and susceptibility to HTG [@pone.0046632-Cheng1]. Therefore, both types of POAG might implicate different genetic susceptibility. In the present meta-analysis, both Q368X and T353I mutation of MYOC were generally shown to confer an increased risk of POAG with elevated IOP, but not for NTG. Although limited number of studies in the stratified analysis might explain, at least in part, the existing inconsistency. The disease-specific observation might suggest that there was different genetic susceptibility between HTG and NTG. Further studies addressing the association of MYOC on HTG and NTG, respectively, are warranted to verify the current findings.

Two previous meta-analyses have assessed the association between MYOC polymorphisms and POAG susceptibility [@pone.0046632-Liu1], [@pone.0046632-Liu2]. A previous meta-analysis, which based on 11 case-control studies, suggested an association of MYOC Q368X mutation and POAG [@pone.0046632-Liu1]. Another meta-analysis of 4 case-control studies suggested that MYOC.mt1 polymorphism does not have significant influence on the risk of POAG development [@pone.0046632-Liu2]. However, the previously published meta-analyses on the association of MOYC and POAG included the relatively less information and failed to confirm a strong and consistent association. The strength of present meta-analysis investigating the relationship between the MOYC polymorphic variant and susceptibility to POAG is based on the large amount of published data giving greater information.

Although we tried to conduct a thorough review of the existing literature, this study has several potential limitations. First, the possibility of selection biases cannot be completely excluded because all of the included studies were observational, and the potential confounding effect of age and sex might make the interpretation of the results and stratified analyses difficult. Second, only five POAG mutations were included in this analysis. Other potential polymorphisms, such as those at G12R, T123T, D208E, T285T, I288I, T325T, K398R, and A488A, were not included. Third, only published studies were included. Although multiple databases and websites were searched, unfortunately, it is possible that we may have failed to include some papers, especially those published in other languages. We can\'t find any evidence of publication bias by funnel plots, however, considerable between-study heterogeneity was found for R76K.

In conclusion, this systematic review summarized the strong evidence for an association between myocilin polymorphisms and POAG. Our results suggested Q368X and T353I variants of myocilin gene can be taken as reference loci for exploring POAG susceptibility, both in high-tension glaucoma. Furthermore, the prevalence of the two mutations of myocilin gene might be ethnicity-dependent, namely, in Caucasians for Q368X and in Asians for T353I.

Methods {#s4}
=======

Search Strategy {#s4a}
---------------

Studies addressing the association between MYOC mutations and polymorphisms and POAG were identified by searching for articles in the PubMed, and EMBASE until 31 December 2011. A broad search strategy combined terms related to gene (including keyword search using *myocilin*, *MYOC*, *trabecular meshwork-induced glucocorticoid response protein*, *TIGR*, *GLC1A*) and terms related to disease (including MeSH search using exp "*glaucoma, open angle*", and keyword search using "*open angle glaucoma*" and its abbreviation). Additional studies were also identified by a hand search of all the references of retrieved articles.

We included only published manuscripts, without any language restriction. All the studies must meet the following inclusion criteria: (1) case-control study; (2) patients had to be POAG; and (3) Only the most widely mutations and polymorphisms were considered: R46X, R76K, Y347Y, T353I, Q368X. Exclusion criteria were: 1) studies with family-based designs; 2) studies on other polymorphisms other than the target polymorphisms.

Data extraction {#s4b}
---------------

Data extraction was performed by two reviewers independently and in duplicate. For each study, the following data were extracted: first authors and publication year, country of origin, study base, study participant ethnicity, numbers of cases and controls, diagnosis criteria, demographic data, and genotype distributions for each polymorphism among cases and controls.

Statistical Analysis {#s4c}
--------------------

The association between MYOC polymorphism and POAG was calculated using co-dominant model. We used the odds ratio (OR) and corresponding 95% confidence intervals (CI) as the metric of choice. The statistical analysis was performed by Comprehensive Meta-Analysis (V2.0; Biostat, Englewood Cliffs, New Jersey, USA). The between-study heterogeneity was tested by the Q test and I^2^ test. If no heterogeneity detected (*P*\>0.1), a fixed effects model was selected to pool the data. A random-effect model, otherwise, was employed after exploring the causes of heterogeneity. Stratified analyses were conducted with respect to ethnicity (Africans, Asians and Caucasians) and diagnosis criteria (NTG, HTG). Begg\'s rank correlation method and Egger\'s weighted regression method were used to statistically assess publication bias.
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